Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
22-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #58505
advertisement
Wang NK
22
Showing records 1 to 22 |
Display all abstracts from
Wang NK
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Wang NK
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Nassisi M
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Liu PK
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Smirnov VM
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Kong Y
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Solis Hernandez C; Mohand-Saïd S
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Levi SR
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Condroyer C
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Huang WC
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Antonio A
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Hsu CW
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Kühlewein L
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Wang HH; Chen N
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Kempf M; Kohl S
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Tseng YJ; Quinn PMJ
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Wissinger B
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Tai MH
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Nasser F; Ragi SD
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Lin CS
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Wang NK
Human Mutation
2021; 42: 641-666
95527
Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
Tsang SH
International journal of molecular sciences
2021; 22:
95528
CNGB1-related rod-cone dystrophy: A mutation review and update
Sparrow JR; Greenstein VC; Michalakis S; Mahroo OA; Ba-Abbad R; Michaelides M; Webster AR; Degli Esposti S; Saffren B; Capasso J; Levin A; Hauswirth WW; Dhaenens CM; Defoort-Dhellemmes S; Tsang SH; Zrenner E; Sahel JA; Petersen-Jones SM; Zeitz C; Audo I
Human Mutation
2021; 42: 641-666
Issue
22-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept